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Summary-The differential actions of i.v. arecoline and nicotine were determined on neocortical 
and limbic system EEG activation in acute rostra1 and caudal midbrain transected cats. All 
animals were prepared under diethyl ether anesthesia and after surgery, paralyzed with deca- 
methonium and maintained on artificial respiration. The peripheral effects of these cholinergic 
agonists were reduced by methyl atropine (250 pg/kg) and/or trimethidinium (1 mg/kg) 
pretreatment. 
In the caudal midbrain transected preparation, nicotine (20-40 pg/kg) induced marked EEG 
activation in both the neocortex and hippocampus. After bilateral lesions of the midbrain reti- 
cular formation in the same preparation, EEG activation was not observed with nicotine indoses 
up to 100 pg/kg. The EEG effects of nicotine were blocked by atropine (1 mg/kg) and mecamyl- 
amine (1 mg/kg) but not trimethidinium (1 mg/kg). In the rostra] midbrain transected 
preparation no EEG activation was noted with nicotine in doses up to 100 pg/kg. Sporadic 
sharp waves appeared in the hippocampus with the larger doses indicating a convulsant site 
of action above the level of transection. 
Arecoline induced dissociation of the EEG in the hippocampus and neocortex in doses of 
20-40 pg/kg in the rostra1 midbrain transected cat. Marked hippocampal slow “arousal” waves 
with no desynchronization of the neocortical EEG were seen. These effects of arecoline were 
blocked by atropine. In the caudal midbrain preparation, even after bilateral lesions of the 
midbrain reticular formation which blocked nicotine activation, arecoline (20-40 rg/kg) still 
induced hippocampal slow ‘arousal’ waves without neocortical desynchronization. With doses 
of 100 rg/kg of arecoline both neocortical and hippocampal EEG activation was noted. 
It is concluded that the site of nicotine on the rostra1 forebrain activating system is located 
primarily in the midbrain reticular formation, whereas arecoline acts on the midbrain reticular 
formation as well as above the level of the mesencephalon. 
RINALDI and HIMWICH (1955a, b) and BRADLEY and ELKEB (1957) were among the first 
to provide evidence for a cholinergic mechanism in mesen-diencephalic structures mediating 
EEG activation. In the intervening years many other investigators have elaborated this 
concept (KILLAM, 1962; SILVETTE et al., 1962; WHITE and BOYAJY, 1959; WHITE, 1963; 
LONCO, 1966; STUMPF, 1965; VOTAVA, 1967). It has been shown that muscarinic (m) and 
nicotinic (n) cholinergic components are involved in EEG activation as evidenced by the 
use of selective 172 and n cholinergic agonists and antagonists (ILYUTCHENOK, 1962; DOMINO 
et al., 1967; YAMAMOTO and DOMINO, 1967). Furthermore, recent neurophysiological 
advances have shown that the mesencephalic reticular formation affects predominantly the 
neocortex while the hypothalamus affects predominantly the limbic system. For example, 
the presence of a specific activating mechanism in the hypothalamus on the hippocampal 
EEG has been shown using the rostra1 midbrain transected (RMT) cat, which lacks the 
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midbrain reticular formation (KAWAMURA et al., 1961; KAWAMURA and OSHIMA, 1962; 
KAWAMURA and DOMINO, 1968). In the RMT cat, threshold electrical stimulation of the 
hypothalamus induced hippocampal EEG activation without desynchronization of the 
neocortex. Although the midbrain reticular formation and hypothalamus have a close 
relationship, especially in the intact animal, there is a functional differentiation. In other 
words, the hippocampal EEG reflects primarily hypothalamic activation, whereas neo- 
cortical desynchronization reflects primarily midbrain reticular influences. 
In view of the fact that the neocortical and hmbic activating mechanisms can be disso- 
ciated, it was important to determine if this would apply to nr and n cholinergic agonists 
which produce EEG activation. This paper describes the differential activating effects of 
arecohne and nicotine, typical m and n chofinergic agonists which readily penetrate the 
blood-brain barrier. 
METHODS 
Thirty cats of both sexes, weighing 2*3-&O kg were used. Jn eighteen cats, the rostra1 
midbrain was transected at the junction between the diencephalon and midbrain. In twelve 
cats, the caudal midbrain was transected from the colliculi down to the anterior border 
of the pons. Tracheotomy was performed under diethyl ether anesthesia and the cat mounted 
in a stereotaxic apparatus. The forearm veins were cannulated for drug injection. The 
wound margins were infiltrated with 1% xylocaine, The method of transecting the brainstem 
at the junction of diencephalon and midbrain (RMT) has been described elsewhere 
(KAWAMURA and DOMINO, 1968). For the caudal midbrain transection (CMT), a trephine 
hole was made in the skull overlying the cerebellum and was made posterior to the bony 
tentorium. Then the cerebeilum was removed by aspiration and the fourth ventricle exposed. 
The brainstem was transected just behind the bony tentorium using a small curved spatula. 
Ether was discontinued after surgery and decamethonium was injected i.v. Respiration 
was maintained by an artificial respirator (Harvard Pump). Blood pressure was recorded 
from the femoral artery with a Statham transducer connected to one channel of a Grass 
polygraph. The neocortical EEG was recorded using phonograph needle electrodes placed 
on the skull such that the tips rested on the dura overlying the frontal and parietal cortices. 
In several cases, the frontal bone was used as reference. For recording electrical activity 
from the hippocampus and for stimulating the brainstem, concentric needle electrodes 
insulated except at the tips were inserted stereotaxically according to the atlas of JASPER 
and AJMONE-MARSAN (1954). Body temperature was monitored during the experiment with 
a rectal thermometer and maintained at 37-38°C with a heating pad placed under the animal. 
For drug injection, freshly prepared nicotine tartarate (40 rLg/ml), arecoline hydro- 
chloride (40 pg/ml), atropine methyl nitrate (250 pg/ml) and trimethidinium (1 mg/ml) were 
used. All drugs were diluted with physiological saline and given as base. Injections were 
given over 30 sec. After each injection, the cannula was flushed immediately with 2 ml of 
physiological saline. 
Electrical activity was recorded by means of a Grass Model 7 polygraph (time constant: 
O-1 sec.) Responsiveness of the forebrain preparation was checked by high frequency 
electrical stimulation of the hypothalamus with square wave pulses (100 cycIes/sec, 1 msec, 
2-5 V for 5 set) delivered from a Grass S 8 stimulator. At the end of an experiment, the 
brain was perfused with 10% formalin. Completeness of transection and electrode locations 
were verified histologically, using cresyl violet or thionine stained serial sections. 
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RESULTS 
Effects of cholinergic agonists on the RMTforebrain 
The i.v. injection of small amounts of arecoline induced marked dissociation of the EEG 
between the neocortex and the hippocampus. The threshold dose inducing hippocampal 
slow waves as an indication of activation was usually 10 pg/kg. In several preparations, 
however, 5 pg/kg induced activation. A larger dose of 20 pg/kg, induced very marked 
dissociation between the hippocampal and neocortical EEG. After 20 pg/kg of arecoline 
iv. and upon recovery from the fall in arterial blood pressure, the hippocampal EEG 
changed from irregular fast waves with spikes to a regular slow 3 cycleslsec activation 
pattern, while the neocortical EEG showed no apparent change except for slight enhance- 
ment of spindle bursts (see Fig. 1). The hippocampal regular slow waves continued for 
3-10 min with a gradual return to the pre-drug state. To prove that this EEG change was not 
due to the fall in systemic blood pressure, methyl atropine (250 ,ug/kg, i.v.) was given to 
reduce the peripheral effects of arecoline. In the same cat, half an hour after pretreatment 
with methyl atropine, the same dose of arecoline no longer altered blood pressure (Fig. 1, 
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FIG. 1. Hippocampal EEG activation induced by arecoline in the rostra1 midbrain transected 
cat. Upper panel: control. An injection of 20 rg/kg of arecoline i.v. induced hypotension with 
3 cycles/set regular slow wave activation of the hippocampus. Note that at this dosage the 
drug did not induce neocortical EEG desynchronization. Lower panel: after methyl 
atropine pretreatment. Although arecoline-induced hypotension was blocked, marked hippo- 
campal activation was still seen, but at a frequency of 2.5 cycles/set. The abbreviations in this 
and following illustrations are: L. FC, left frontal cortex-frontal bone; R. FC, right frontal 
cortex-frontal bone; L. FC-PC, left frontal cortex-parietal cortex; R. FC-PC, right frontal 
cortex-parietal cortex; L. HPC, left hippocampus; monopolar recordings were taken to the 
nasal bone B.P., blood pressure; EKG, electrocardiogram, lead 1. 
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lower panel). Hippocampal activation was elicited with the same time course as previously, 
although the frequency of the hippocampal regular slow waves was slightly lower (2+2*5 
cycles/set). 
As the dose of arecoline was increased, the neocortical EEG was more affected. In 
responsive RMT preparations whose brainstem was transected at the junction of midbrain 
and diencephalon, increasing the dose of arecoline to 50-100 pg/kg produced suppression 
of slow waves and spindle bursts in the neocortex in addition to continued marked hippo- 
campal activation. Low voltage fast waves appeared in the neocortex with doses of 100 pg/kg 
or more of arecoline. Desynchronization was observed more readily when the transection 
was caudal and part of the midbrain remained with the forebrain. EEG changes bore no 
relation to blood pressure. The EEG differences between the effects of a small (20 pg/kg) and 
large (100 pg/kg) doses of arecoline are illustrated in Fig. 2. In the RMT preparation, 
IoOY/kg 
FIG. 2. Effect of increasing doses of arecoline on the EEGoftherostral midbrain transected cat. 
After transection the animal was given 250 pg/kg of methyl atropine and tested within half an hr. 
Upper panel: before arecoline injection the neocortical and hippocampal EEG show the 
typical slow waves and spikes. About 60 set after 20 rg/kg of arecoline i.v. hippocampal regular 
slow waves were observed while the neocortical EEG showed no desynchronization but some 
increase in fast waves and a slight suppression of slow wave activity. Lower panel: before 
injection typical slow wave and spike-like activity was present. After 100 pg/kg of arecoline, 
there was a suppression of slow waves and appearance of a low voltage fast wave pattern in the 
neocortex as well as hippocampal regular slow wave activation. 
pretreated with 250 pg/kg methyl atropine half an hour previously, 20 pg/kg of arecoline 
produced marked hippocampal activation, while the neocortex showed only an increase in 
fast activity superimposed on a background of slow waves. However, following 100 pg/kg of 
arecoline the neocortex showed marked suppression of slow waves and a low voltage fast 
pattern appeared. Thus, in the RMT preparation, small doses of arecoline induced marked 
dissociation of the EEG of the neocortex and limbic system. With large doses, the neocortex 
showed desynchronization. Atropine (1 mg/kg, i.v.) blocked the EEG activating effect of 
20-100 pg/kg of arecoline in the RMT forebrain. 
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In the RMT preparation, 20-40 rg/kg of nicotine did not produce significant activation 
in the hippocampus (Fig. 3) although similar doses caused marked activation of both 
neocortex and hippocampus in the intact or CMT cat. In the RMT preparation without 
trimethidinium pretreatment, 20 pg/kg of nicotine induced a marked hypertension associated 
with sporadic sharp waves localized to the hippocampus. After 1 mg/kg of trimethidinium 
the pressor response to nicotine was completely blocked and no EEG change was seen in 
the hippocampus. With larger doses of 200-500 pg/kg, hippocampal sharp waves were some- 
RDSTRAL MIDBRAIN TRANSECTED CAT 
CAT RMT K--,8 
BEFORE INJECTION ,Wsec AFTER NICOTINE LV 2074 
loo Y/kg 
FIG. 3. Effect of increasing doses of nicotine on the EEG of the rostra1 midbrain transected 
cat. Following transection 1 mg/kg, i.v. of trimethidinium was given as pre-treatment. Upper 
panel; 1 hr later 20 pg/kg of nicotine i.v. had no effect in contrast to arecoline (see Fig. 2). 
Lower panel : A dose of nicotine 5 times as great (100 pg/kg) induced sporadic sharp waves in the 
hippocampus although there was no significant change in the neocortical EEG slow wave 
pattern. 
times followed by seizure discharges. In several cats, enhancement of EEG activation by 
nicotine (20-40 pg/kg) was seen when nicotine was injected after arecoline (20-40 pg/kg) in 
both RMT and CMT preparations. On the other hand, when arecoline was given after 
nicotine there was no evidence of any influence from the nicotine. Therefore, in order to 
draw conclusions concerning the actions of nicotine, arecoline was never given prior to 
nicotine in these experiments. 
Eflects of nicotine and arecoline in the CMTforebrain 
If the midbrain was transected caudally at the junction of the pons, both nicotine and 
arecoline induced neocortical desynchronization as well as hippocampal regular slow 
“arousal” waves. Such EEG activation was induced even when blood pressure remained 
constant by pretreatment with trimethidinium for nicotine and methyl atropine for arecoline. 
Whenever a blood pressure change occurred, the EEG changes were of longer duration 
and consisted of waves of higher frequency. After bilateral lesions of the midbrain teg- 
mentum, the EEG activating effect of nicotine was completely blocked. Figure 4 illustrates 
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T;rc;. 4. EEG activation induced by nicotine in the caudal midbrain transected cat. Upper 
panel: the i.v. injection of 20 Clgjky of nicotine produced marked h~I~ertensj~~ and dramatic 
EEG activation both in the neocortex and bippocampus. Middle panel: I hr after 1 mJkg vf 
trimetbidjnium i.v. the same dose of nicotine still produced EEG activation in the absence of a 
change in blood pressure. The intensity of EEG activation was not as great, aIt~~u$~ still 
clearly evident. Lower panel: after bilateral lesions of the midbra~ reticular formation, even 
a larger dose of nicotine (40 ygjkg} did not activate the EEG. This was true even tool the 
interval between nicotine injections was mare than t & hr to avoid tacbyphyl~~s. 
this phenomenon in a preparation in which the caudat midbrain was transected. To further 
eliminate a&rent impulses from the periphery which might cause activation, the optic 
nerves and olfactory tracts were cut bilaterally in three cats. Similar results were obtained 
indicating that these afferents have no effect on forebrain activation induced by nicotine 
or arecofine. 
fn intact animals nicotine in doses of 20 pg/kg, Lv. induced marked hypertension 
(up to 200 mm Hg) with bradycardia, simultaneous desyn~hron~~at~~~ of the neocorticaf 
EEG and enhancement of hi~~ocampa~ regular slow “arousal*’ waves as ilIustrat~d in the 
recording in the upper panel of Fig. 4. After pretreatment wits I mgJkg of trimethjdi~um 
1 hr pre~~j~usIy a second dose of nicotine (233 &kg, i.v,) produced no chaage in blood 
pressure but neocortical ~esy~~hr~n~~ti~n and h~~po~arn~a~ “arousai” waves&if appeared. 
Differential actions of m and n cholinergic agonists on the brainstem activating system 111 
However, the duration of activation and the frequency of the EEG waves were lower than 
before trimethidinium. Bilateral electrolytic lesions of the midbrain reticular formation in 
such preparations completely prevented the EEG actions of nicotine even in doses of 
40 pg/kg, i.v. The location of the midbrain tegmental lesions in one typical cat in which an 
extensive bilateral lesion prevented nicotine induced EEG activation is illustrated diagram- 
atically in Fig. 5. After such midbrain reticular formation lesions, nicotine no longer 
i 
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FIG. 5. Schematic diagram of the localization of the lesions of the midbrain reticular formation 
which blocked nicotine induced activation. The areas outlined by the slanted lines indicate 
the size of the lesion which occupies the area from the tip of the midbrain to the caudal portion 
of the midbrain near the pons. 
activated the neocortical EEG, even in doses up to 100 pg/kg. However, arecoline (20-40 
pg/kg) still induced marked activation in the hippocampus, and both neocortical and 
hippocampal activation with larger doses. These effects are illustrated in Fig. 6in the EEG 
recordings selected from one cat. Trimethidinium (1 mg/kg, i.v.) was given before nicotine 
and methyl atropine (250 pg/kg) before arecoline. In the CMT preparation, a small amount 
of nicotine (20 pg/kg, i.v.) induced EEG activation in both the neocortex and hippocampus. 
After bilateral lesions of the midbrain reticular formation, doses up to 100 pg/kg showed no 
effect on the EEG. In such a preparation following arecoline (40 pg/kg, i.v.) the hippocampal 
EEG showed a clear change from the preinjection pattern of irregular fast waves with spikes 
to a regular slow “arousal” pattern, but the neocortex showed little desynchronization. 
With this dose of arecoline there was an obvious dissociation between the neocortical and 
hippocampal EEG activation in the RMT preparation. These effects were blocked by 
atropine (1 mg/kg, i.v.) In addition, in the CMT preparation, atropine blocked both 
arecoline and nicotine EEG activation. 
In an additional series of experiments, electrolytic lesions were made in the inter- 
peduncular nucleus in 5 CMT cats. In these lesioned preparations nicotine activation of the 
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FIG. 6. Differential effects of nicotine and arecoline in a caudal midbrain transected cat with 
bilateral lesions of the reticular formation. Upper panel: following trimethidinium pretreatment 
nicotine (20 pg/kg) induced desynchronization of the neocortex and hippocampal slow waves 
for a short period of time. Middle panel: after bilateral lesions of the midbrain reticular 
formation injection of nicotine in an even larger dose (40 rg/kg) did not produce EEG activation. 
Lower panel : in contrast to the lack of effects of nicotine, after methyl atropine pretreatment (250 
pg/kg) a similar dose of arecoline caused the appearance of hippocampal slow wave activation in 
the absence of neocortical EEG desynchronization. 
neocortical and hippocampal EEG was still observed indicating that the interpeduncular 
nucleus is not critical for this phenomenon. 
DISCUSSION 
The midbrain reticular formation is an indispensable structure for the activation of the 
forebrain EEG by nicotine. A lesion in this area prevents nicotine induced tonic activation 
of the neocortical EEG. These conclusions are based upon experiments in the CMT 
preparation in which most afferent impulses from the periphery were blocked as well as in 
additional preparations in which the optic nerves and olfactory tracts were transected. 
The fact that a small amount of arecoline can activate the hippocampal EEG in a deafferen- 
tiated forebrain, which lacks the midbrain reticular formation bilaterally, indicates that 
arecoline has a direct effect on a forebrain activating mechanism, possibly on the hypo- 
thalamus as based upon the results from our earlier stimulation experiments in RMT cats 
(KAWAMURA and DOMINO, 1968). 
The EEG activating effects of arecoline or nicotine in the brainstem transected forebrain 
is not due to the action of the drug on the transected surface where the blood-brain barrier 
is seriously damaged, because both drugs are known to pass the blood-brain barrier 
readily and the xylocaine infiltration of the surface of the transected brainstem has no 
influence on their activating effect. 
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Nicotine and arecoline have marked peripheral cardiovascular effects. In order to 
block the direct effect of systemic blood pressure changes on the mesen-diencephalic 
pressure sensitive areas (BAUST et al., 1963), appropriate doses of cholinergic antagonists 
for each drug were given as pretreatment. Trimethidinium, 1 mg/kg, iv. was given to reduce 
the ~ripheral effects of nicotine and methyl atropine, 250 pg/kg, iv. to reduce the peripheral 
effects of arecoline. Such pretreatment successfulty prevented any marked changes in 
systemic blood pressure. Whereas arecoline induced marked hippocampal EEG changes in 
the RMT preparation, nicotine did not. The lack of effect of nicotine on hippocampal 
activation even though there was marked hypertension (prior to trimethidinium) indicated 
further that the EEG effects observed were basically unrelated to changes in blood pressure. 
In addition, the i.v. injection of large doses of epinephrine (5 pg/kg) induced a marked 
increase in blood pressure without EEG activation in the RMT preparation, indicating 
that hypertension was not the main factor responsible for EEG activation. Thus, one can 
conclude that the cholinergic agonists themselves are responsible for inducing EEG acti- 
vation, although their peripheral cardiovascular effects do prolong and enhance their 
action on the brainstem activating system. 
The EEG desynchronizing actions of nicotine have been reported in the inferior 
collicular-midpontine transected rabbit, cat and dog (KNAPP and DOMINO, 1962), as well 
as in the cerveau isol rabbit (FLORIS et al., 1963). It should be noted that in all these 
preparations, the midbrain reticular formation was partically connected to the forebrain. 
Similarly, in the present series of experiments, the more caudal the midbrain transection, 
the easier it was to activate the EEG with nicotine. ft would appear that the midbrain 
reticular formation is the most important structure for EEG activation of the forebrain 
by nicotine. The more caudally located reticular formation appears to enhance this effect. 
This finding is in accord with the results of earlier investigators. Even 100 pg/kg of nicotine 
could not induce significant neocortical or hippocampal EEG activation in the RMT 
preparation which lacks the midbrain reticular formation. However, arecoline in small 
doses in the same RMT preparation easily induced hippocampal EEG activation. Likewise, 
in the CMT preparation in which the midbrain reticular formation was destroyed bilaterally, 
nicotine did not activate the neocortical or hippocampal EEG, while arecoline still induced 
hippocampal activation. 
Large doses of nicotine (l-5 mg/kg) are known to induce seizure discharges, particularly 
in the hippocampus (STUMPF et al., 1962; STUMPF and GOGOLAK, 1967). According to 
SCHMIT~RL~W ef al. ~1967),injectionof1~C-labeled nicotine localizes in high concentrations in 
the archicortex, especially in the molecular and pyramidal cell layers of the hippocampus. On 
the basis of the present experiments nicotine may produce hippocampalseizuredischargesas a 
direct effect. It has also been shown by SCHMUERL~~W et al. (1967) that the interpeduncular 
nucleus also contains very high concentrations of injected 14C-nicotine in the cat. However, a 
lesion of the interpeduncular nucleus in the CMT cat failed to block EEG activation induced 
by nicotine. Although the concentration of I*C-nicotine in the midbrain reticular formatioll 
is not high (SCHMITERL~W et al., 1967) it seems that this area is either very sensitive to 
nicotine or part of a critical circuit of neurons responsible for inducing EEG activation. 
It appears that in small doses nicotine first activates the EEG as a result of stimulating the 
midbrain reticular formation, and in larger doses, induces seizures, initially in the hippo- 
campus. Sporadic high frequency sharp waves, which were sometimes observed in the 
hippocampus in the RMT preparation following large doses of nicotine may have been 
the first sign of seizure activity. The failure of nicotine to induce hippocampal slow wave 
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activation in the RMT preparation indicates this action is indirect and involving the 
reticular formation below the level of transection. 
It is of interest that there are relatively few cholinergic neurons in the brain that respond 
to nicotine. It has been shown by ECCLES et al. (1954, 1956) that the Renshaw cells in the 
spinal cord are stimulated by nicotine. The fact that mecamylamine blocks this action 
suggests that this is an n cholinergic action (UEKI et al., 1961), although both m and II 
cholinergic receptors are present on Renshaw cells (CURTIS and RYALL, 1964). It is of 
interest that no n cholinergic neurons have been found in the neocortex (KRNJEVI~ and 
PHILLIS, 1963a, b). However, BRADLEY and WOLSTENCROFT (1967) have reported that 
iontophoretic injection of nicotine in the brainstem activates some neurons. Although thereare 
both nicotinic andmuscarinic neurons inthebrainstem the muscarinic cells have a much wider 
distribution. The present experiments suggest that the brainstem activating system contains 
111 cholinergic neurons in both the midbrain and diencephalon while n cholinergic neurons 
are located primarily in the midbrain reticular formation. However, to prove this hypothesis, 
precise microphysiological studies clarifying such a cell distribution are necessary. 
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